Doctor profile · Federal record

Dr. Ashley Falis, P.A.

Physician Assistant · Medical Physician Assistant · Surgical Physician Assistant · Rockaway, NJ

  • NPI 1730217241
  • Accepts Medicare
  • MIPS 0.0 / 100 · 2023
  • 24 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 3 locations .

NPPES Updated May 11, 2026
Primary practice
35 Green Pond RD
Rockaway, NJ 078662013
(973) 586-7447
fax (973) 586-7445
Additional location
1616 Route 72 W
Manahawkin, NJ 080505131
(732) 234-7546
Additional location
214 Commons Way Bldg B
Toms River, NJ 087556427
(732) 234-7546

Credentials & registration

NPPES · NUCC
NPI registered
February 2007 — 19 yrs on file
Profile last updated
July 8, 2024
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
363A00000X — NUCC code
State license (1)
New Jersey #25MP00104800

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1730217241. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
3,417
Distinct HCPCS
10
Medicare allowed
$167,750
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,088 130 $6
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 415 39 $1
11102 Biopsy of related skin growth, first growth 366 273 $90
99214 Established patient office or other outpatient visit, 30-39 minutes 361 223 $115
99213 Established patient office or other outpatient visit, 20-29 minutes 307 232 $82
11103 Biopsy of related skin growth, each additional growth 266 131 $47
17000 Destruction of precancer skin growth, 1 growth 254 172 $45
99204 New patient office or other outpatient visit, 45-59 minutes 63 63 $138
11900 Injection into skin growth, 1-7 growths 51 29 $39
17004 Destruction of precancer skin growth, 15 or more growths 44 28 $158

In context: peer comparison

Among 1 peers in Rockaway Physician Assistant, average services per provider: 189. This provider delivers 18× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,402
Transactions
116
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 17 $424.46
Medimetriks Pharmaceuticals, INC. 1 $250.00
Sun Pharmaceutical Industries INC. 10 $213.23
Genzyme Corporation 8 $210.54
Abbvie INC. 16 $201.66
Leo Pharma INC. 9 $200.56
Verrica Pharmaceuticals INC. 13 $183.28
E.R. Squibb & Sons, L.L.C. 11 $153.61
Regeneron Healthcare Solutions, INC. 7 $114.60
Incyte Corporation 6 $97.23
Amgen INC. 5 $86.78
Lilly USA, LLC 5 $84.27
Mayne Pharma Commercial LLC 5 $40.57
Dermavant Sciences, INC. 2 $33.72
Medline Industries Lp 1 $28.75

By nature of payment

Food and Beverage
$2,152
Consulting Fee
$250

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
921
Patients
551
Total drug cost
$263,267
Drug Type Claims Patients Total cost
Ketoconazole Generic 195 109 $5,397
Triamcinolone Acetonide Generic 192 140 $2,011
Nystatin Generic 63 36 $1,408
Clindamycin Phosphate Generic 53 27 $1,547
Hydroxyzine Hcl Generic 53 26 $523
Mometasone Furoate Generic 53 44 $1,867
Otezla (Apremilast) Brand 52 0 $238,883
Hydrocortisone Generic 48 35 $445
Metronidazole Generic 41 32 $3,151
Clobetasol Propionate Generic 40 28 $2,787

Frequently asked questions

Auto-generated from federal data
What is Dr. Ashley Falis's medical specialty?
Dr. Ashley Falis practices Physician Assistant in Rockaway, NJ.
Where does Dr. Ashley Falis practice?
Dr. Ashley Falis practices at 35 Green Pond RD, Rockaway, NJ 078662013. Office phone: 9735867447.
What is Dr. Ashley Falis's NPI?
Dr. Ashley Falis's National Provider Identifier (NPI) is 1730217241, issued by NPPES.
Does Dr. Ashley Falis accept Medicare assignment?
Yes. Dr. Ashley Falis accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ashley Falis commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.